OverT Bio
4 known investors
Overt Bio develops cell therapies that link genes to immune functions using genome-scale discovery platforms. The company builds programmable immunotherapies targeting cancer patients.
AI & Machine LearningBiotechMedical Devices
Founders & leadership
DL
Dr. LegutCo-Founder and CEO
DS
Dr. SanjanaCo-Founder
Investors · 4
In the news
- OverT Bio - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2024
- OverT Bio - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2024
- OverT Bio secures $16m in seed funding for cell therapy developmentpharmaceutical-business-review.com · 2024
- OverT Bio Secures $16M to Optimize Cell Therapy for Solid Tumorshitconsultant.net · 2024
- OverT Bio Raises $16M in Seed Fundingfinsmes.com · 2024
- OverT Bio Raises $16 Million, Tapping Innovative Reprogramming of Immune Cells to Deliver Next-Generation Therapiesbusinesswire.com · 2024